Company profile: Cepheid
1.1 - Company Overview
Company description
- Provider of accurate, easy-to-use molecular diagnostic systems and tests that automate complex procedures for institutions of any size. Offerings include the GeneXpert System and single-use Xpert cartridges for nucleic acid extraction, amplification, and detection, plus Xpert Xpress PCR tests for Strep A, SARS-CoV-2, CoV-2/Flu/RSV, and Flu A/B.
Products and services
- Xpert Test Cartridges: Single-use cartridges performing nucleic acid extraction, amplification, and detection with automated molecular diagnostic testing for streamlined workflows across diverse settings
- GeneXpert System: Flexible platform delivering a range of molecular diagnostic assays suitable for core laboratories and near‑patient applications, supporting deployment in varied clinical settings
- Xpert Xpress CoV-2 plus: PCR-based test detecting SARS‑CoV‑2 via three gene targets, offering precise molecular identification of the virus in diagnostic settings
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cepheid
Tavotek Biotherapeutics
HQ: United States
Website
- Description: Provider of therapeutic medicine discovery, development and commercialization, with platforms and programs including TavoSelect phage display to discover diversified human antibody sequences for biologics and diagnostics; TavoPrecise to develop optimized mono- and multi-specific biologics; TavoELITE to address intracellular undruggable targets; and oncology and immunology therapeutics for cancer, inflammatory and allergic diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tavotek Biotherapeutics company profile →
Quanterix
HQ: United States
Website
- Description: Provider of ultrasensitive biomarker detection solutions for healthcare, leveraging Simoa technology to enable earlier disease detection and improved treatment by measuring biomarkers at lower levels. Offerings include Simoa assays across neurology, oncology, cardiology, immunology and infectious disease; the HD-X automated immunoassay analyzer; SP-X and SR-X detection systems; and the CLIA-certified Simoa Accelerator Laboratory.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quanterix company profile →
Singular Genomics
HQ: United States
Website
- Description: Provider of genomic technologies built on the Singular Sequencing Engine, including the G4 benchtop sequencer for a wide range of genomic applications and flexible sample processing; the G4X spatial sequencing platform for multiomic analysis of FFPE samples at subcellular resolution; and consumables such as Max Read, F2/F3 kits, library compatibility kits, indices and adapters.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Singular Genomics company profile →
Genoplan
HQ: Japan
Website
- Description: Provider of DNA testing and genetic analysis services, offering health risk prediction to support informed decisions, pregnancy genetic testing to identify genetic disorder risks for family planning, and traits & ancestry insights into characteristics and lineage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genoplan company profile →
WellGen
HQ: United States
Website
- Description: Provider of plant-based wellness products discovered and developed using nutrigenomics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WellGen company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cepheid
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cepheid
2.2 - Growth funds investing in similar companies to Cepheid
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cepheid
4.2 - Public trading comparable groups for Cepheid
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →